• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

倍氯米松、色甘酸和茶碱治疗对支气管哮喘患者支气管收缩感知的影响。

Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma.

作者信息

Higgs C M, Laszlo G

机构信息

Respiratory Department, Bristol Royal Infirmary, U.K.

出版信息

Clin Sci (Lond). 1996 Mar;90(3):227-34. doi: 10.1042/cs0900227.

DOI:10.1042/cs0900227
PMID:8777828
Abstract
  1. Perception of asthma by patients can be assessed from the relationship between symptom scores and peak expiratory flows. This study was designed to investigate the possibility that medication can affect perception of the sensation of asthma independently of changes in lung function. 2. Twelve subjects whose asthma was inadequately controlled by inhaled bronchodilator alone were studied during four different drug treatments over 3 months. Subjective self-assessment of asthma was scored on a 10 cm visual analogue scale and followed by three consecutive measurements of peak expiratory flow, using a coded electronic peak flow meter. This was recorded not less than three times daily on diary cards. Observations were recorded during the second week of each of four treatments: (i) a run-in period using only inhaled salbutamol as required, (ii) inhaled beclomethasone, (iii) inhaled cromoglycate and (iv) oral theophylline at a dose adjusted to achieve blood levels of 10-20 mg/l. Inhaled salbutamol was permitted during the other treatments as required. Changes in the slope and position of the regression lines of asthma scores on PEF were used to measure changes in perception of asthma on each treatment. Dynamic lung volumes were measured in the clinic before the study and after each treatment period. 3. In the group as a whole, theophylline improved lung function (mean peak flow and dynamic lung volumes) without affecting mean visual analogue scores, beclomethasone improved mean visual analogue scores with much less effect on lung function, while cromoglycate had a small though consistent effect on both. 4. Perception of asthma, measured by the relationship between peak flow rate and visual analogue scores, was unaffected by cromoglycate. On theophylline, perception of asthma was heightened in five subjects despite a definite improvement in their peak flow. On beclomethasone, perception of asthma was reduced in most subjects, often with no discernible improvement in mean peak flow or dynamic spirometry. 5. Perception of bronchoconstriction in asthma can be affected by drugs independently of control of the condition. Theophylline may produce a paradoxical increase in awareness of asthma in some individuals. With beclomethasone therapy a reduction in symptoms of asthma may occur without any improvement in tests of air flow.
摘要
  1. 可通过症状评分与呼气峰值流速之间的关系来评估患者对哮喘的感知。本研究旨在调查药物是否能独立于肺功能变化而影响对哮喘感觉的感知。2. 对12名仅通过吸入支气管扩张剂无法充分控制哮喘的受试者,在3个月内进行了四种不同药物治疗的研究。哮喘的主观自我评估采用10厘米视觉模拟量表评分,随后使用编码电子峰值流量计连续三次测量呼气峰值流速。每天至少在日记卡上记录三次。在四种治疗的每一种的第二周进行观察:(i) 仅根据需要使用吸入沙丁胺醇的导入期,(ii) 吸入倍氯米松,(iii) 吸入色甘酸,(iv) 口服氨茶碱,剂量调整至血药浓度达到10 - 20毫克/升。在其他治疗期间,根据需要可使用吸入沙丁胺醇。用哮喘评分与呼气峰值流速回归直线的斜率和位置变化来衡量每种治疗中对哮喘感知的变化。在研究前及每个治疗期后在诊所测量动态肺容量。3. 总体而言,氨茶碱改善了肺功能(平均峰值流速和动态肺容量),但不影响平均视觉模拟评分;倍氯米松改善了平均视觉模拟评分,对肺功能的影响小得多;而色甘酸对两者都有虽小但持续的影响。4. 用峰值流速与视觉模拟评分之间的关系衡量的对哮喘的感知不受色甘酸影响。使用氨茶碱时,尽管五名受试者的峰值流速有明显改善,但他们对哮喘的感知增强。使用倍氯米松时,大多数受试者对哮喘的感知降低,且平均峰值流速或动态肺量计通常无明显改善。5. 哮喘中支气管收缩的感知可受药物影响,且独立于病情控制情况。氨茶碱在某些个体中可能会反常地增加对哮喘的感知。使用倍氯米松治疗时,哮喘症状可能减轻,而气流测试无任何改善。

相似文献

1
Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma.倍氯米松、色甘酸和茶碱治疗对支气管哮喘患者支气管收缩感知的影响。
Clin Sci (Lond). 1996 Mar;90(3):227-34. doi: 10.1042/cs0900227.
2
Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction.倍氯米松和沙美特罗对乙酰甲胆碱诱导的支气管收缩感知的影响。
Chest. 1998 Aug;114(2):373-9. doi: 10.1378/chest.114.2.373.
3
Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double-dummy randomized, parallel-group study.色甘酸钠(定量吸入器)与二丙酸倍氯米松(定量吸入器)治疗成人轻至中度支气管哮喘的比较。一项双盲、双模拟随机平行组研究。
Allergy. 1994 Sep;49(8):659-63. doi: 10.1111/j.1398-9995.1994.tb00136.x.
4
Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study.低剂量茶碱联合倍氯米松对哮喘吸烟者肺功能的影响:一项初步研究。
Eur Respir J. 2009 May;33(5):1010-7. doi: 10.1183/09031936.00158208. Epub 2009 Feb 5.
5
Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma.在哮喘治疗中,将茶碱添加到吸入性类固醇与将吸入性类固醇剂量加倍的比较。
Eur Respir J. 1997 Dec;10(12):2754-60. doi: 10.1183/09031936.97.10122754.
6
Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.通过添加吸入性糖皮质激素减缓支气管扩张剂治疗期间观察到的哮喘和慢性阻塞性肺疾病的恶化。一项为期4年的前瞻性研究。
Ann Intern Med. 1993 May 15;118(10):770-8. doi: 10.7326/0003-4819-118-10-199305150-00003.
7
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.沙美特罗添加至吸入性糖皮质激素与吸入性糖皮质激素剂量加倍的比较。
Am J Respir Crit Care Med. 1996 May;153(5):1481-8. doi: 10.1164/ajrccm.153.5.8630590.
8
Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice.高剂量吸入性类固醇、低剂量吸入性类固醇加低剂量茶碱以及单独使用低剂量吸入性类固醇在全科医疗中治疗慢性哮喘的比较
Thorax. 2000 Oct;55(10):837-41. doi: 10.1136/thorax.55.10.837.
9
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate to severe asthma.吸入性糖皮质激素联合茶碱与双倍剂量吸入性糖皮质激素治疗中重度哮喘的比较
Respirology. 2005 Mar;10(2):189-95. doi: 10.1111/j.1440-1843.2005.00697.x.
10
Lung function and asthma control with beclomethasone and formoterol in a single inhaler.布地奈德福莫特罗单吸入器对肺功能及哮喘控制的影响
Respir Med. 2009 Jan;103(1):41-9. doi: 10.1016/j.rmed.2008.09.002. Epub 2008 Nov 1.

引用本文的文献

1
Mechanisms, measurement and management of exertional dyspnoea in asthma: Number 5 in the Series "Exertional dyspnoea" Edited by Pierantonio Laveneziana and Piergiuseppe Agostoni.哮喘运动性呼吸困难的机制、测量与管理:“运动性呼吸困难”系列第5号,由皮耶尔安东尼奥·拉韦内齐亚纳和皮耶尔朱塞佩·阿戈斯托尼编辑
Eur Respir Rev. 2017 Jun 14;26(144). doi: 10.1183/16000617.0015-2017. Print 2017 Jun 30.
2
Research priorities in biomarkers and surrogate end-points.生物标志物和替代终点的研究重点。
Br J Clin Pharmacol. 2012 Jun;73(6):900-7. doi: 10.1111/j.1365-2125.2012.04234.x.
3
Perception of airway obstruction and airway inflammation in asthma: a review.
哮喘中气道阻塞与气道炎症的认知:综述
Lung. 2006 Sep-Oct;184(5):251-8. doi: 10.1007/s00408-005-2590-z.
4
Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.吸入性皮质类固醇与色甘酸钠用于儿童和成人哮喘患者的比较
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD003558. doi: 10.1002/14651858.CD003558.pub2.
5
Current perspectives on symptom perception in asthma: a biomedical and psychological review.哮喘症状感知的当前观点:生物医学与心理学综述
Int J Behav Med. 1999;6(2):120-34. doi: 10.1207/s15327558ijbm0602_2.
6
Biomarkers and surrogate endpoints.生物标志物与替代终点
Br J Clin Pharmacol. 2005 May;59(5):491-4. doi: 10.1111/j.1365-2125.2005.02435.x.
7
Association of sputum parameters with clinical and functional measurements in asthma.哮喘患者痰液参数与临床及功能指标的相关性
Thorax. 2000 Mar;55(3):235-8. doi: 10.1136/thorax.55.3.235.